LILLY TUNELAB Trademark

Trademark Overview

On Tuesday, January 7, 2025, a trademark application was filed for LILLY TUNELAB with the United States Patent and Trademark Office. The USPTO has given the LILLY TUNELAB trademark a serial number of 98941907. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, May 20, 2025. This trademark is owned by Eli Lilly and Company. The LILLY TUNELAB trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical information; Medical analysis for the diagnosis and treatment of persons

Product development; Pharmaceutical products development; Biological product development services; Research and development services in the field of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Scientific research and development; Pharmaceutical product evaluation during product development; Scientific research consulting; Research and development in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Providing information relating to scientific research in the fields of biochemistry and biotechnology; Compiling data for research purposes in the field of medical science and pharmaceutical drug development
lilly tunelab

General Information

Serial Number98941907
Word MarkLILLY TUNELAB
Filing DateTuesday, January 7, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, May 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 10, 2025

Trademark Statements

Pseudo MarkLILLY TUNE LAB
Goods and ServicesMedical information; Medical analysis for the diagnosis and treatment of persons
Goods and ServicesProduct development; Pharmaceutical products development; Biological product development services; Research and development services in the field of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Scientific research and development; Pharmaceutical product evaluation during product development; Scientific research consulting; Research and development in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Providing information relating to scientific research in the fields of biochemistry and biotechnology; Compiling data for research purposes in the field of medical science and pharmaceutical drug development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 7, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 7, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Tuesday, January 7, 2025NEW APPLICATION ENTERED
Tuesday, April 29, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 2, 2025ASSIGNED TO EXAMINER
Thursday, May 8, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, May 8, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 8, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, May 8, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, May 8, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 4, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Related Keywords

tunelab lilly development research pharmaceutical product medical services scientific biotechnology field information